HRAS and cancer: Considering the Afirma Gene Expression Classifier and ThyroSeq genomic classifier are not yet available in China and are expensive, 5 of the most common cancer-associated somatic mutations (BRAF, HRAS, NRAS, KRAS and TERT) were offered in our hospital.